120 related articles for article (PubMed ID: 19156464)
1. Bevacizumab-related surgical site complication despite primary tumor resection in colorectal cancer patients.
Bège T; Lelong B; Viret F; Turrini O; Guiramand J; Topart D; Moureau-Zabotto L; Giovannini M; Gonçalves A; Delpero JR
Ann Surg Oncol; 2009 Apr; 16(4):856-60. PubMed ID: 19156464
[TBL] [Abstract][Full Text] [Related]
2. "Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy.
August DA; Serrano D; Poplin E
J Surg Oncol; 2008 Feb; 97(2):180-5. PubMed ID: 18095268
[TBL] [Abstract][Full Text] [Related]
3. [Leakage of colorectal anastomosis after neoadjuvant therapy with bevacizumab. Case report].
Scabini S; Pertile D; Boaretto R; Rimini E; Romairone E; Scordamaglia R; Ferrando V
G Chir; 2009 Oct; 30(10):413-6. PubMed ID: 19954580
[TBL] [Abstract][Full Text] [Related]
4. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.
Scappaticci FA; Fehrenbacher L; Cartwright T; Hainsworth JD; Heim W; Berlin J; Kabbinavar F; Novotny W; Sarkar S; Hurwitz H
J Surg Oncol; 2005 Sep; 91(3):173-80. PubMed ID: 16118771
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal perforation due to bevacizumab in colorectal cancer.
Saif MW; Elfiky A; Salem RR
Ann Surg Oncol; 2007 Jun; 14(6):1860-9. PubMed ID: 17356952
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemoradiation increases the risk of pelvic sepsis after radical excision of rectal cancer.
Buie WD; MacLean AR; Attard JA; Brasher PM; Chan AK
Dis Colon Rectum; 2005 Oct; 48(10):1868-74. PubMed ID: 16175323
[TBL] [Abstract][Full Text] [Related]
7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
8. The effects of bevacizumab on postoperative complications in patients undergoing colorectal and pancreatic cancer resection.
Cheon EC; Small W; Strouch MJ; Krantz SB; Rademaker A; Mulcahy MF; Benson AB; Bentrem DJ; Talamonti MS
J Surg Oncol; 2010 Oct; 102(5):539-42. PubMed ID: 20812264
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer.
Thornton AD; Ravn P; Winslet M; Chester K
Br J Surg; 2006 Dec; 93(12):1456-63. PubMed ID: 17115389
[TBL] [Abstract][Full Text] [Related]
10. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.
Kesmodel SB; Ellis LM; Lin E; Chang GJ; Abdalla EK; Kopetz S; Vauthey JN; Rodriguez-Bigas MA; Curley SA; Feig BW
J Clin Oncol; 2008 Nov; 26(32):5254-60. PubMed ID: 18854565
[TBL] [Abstract][Full Text] [Related]
11. Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study.
Tamandl D; Gruenberger B; Klinger M; Herberger B; Kaczirek K; Fleischmann E; Gruenberger T
Ann Surg; 2010 Jul; 252(1):124-30. PubMed ID: 20562613
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab-associated fistula formation in postoperative colorectal cancer patients.
Ganapathi AM; Westmoreland T; Tyler D; Mantyh CR
J Am Coll Surg; 2012 Apr; 214(4):582-8; discussion 588-90. PubMed ID: 22321523
[TBL] [Abstract][Full Text] [Related]
13. Postoperative complications following neoadjuvant bevacizumab treatment for advanced colorectal cancer.
Yoshioka Y; Uehara K; Ebata T; Yokoyama Y; Mitsuma A; Ando Y; Nagino M
Surg Today; 2014 Jul; 44(7):1300-6. PubMed ID: 23942819
[TBL] [Abstract][Full Text] [Related]
14. Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer.
Hompes D; Ruers T
Eur J Surg Oncol; 2011 Sep; 37(9):737-46. PubMed ID: 21764243
[TBL] [Abstract][Full Text] [Related]
15. Improvement of colonic healing by preoperative rectal irrigation with short-chain fatty acids in rats given radiotherapy.
Terzi C; Sevinç AI; Koçdor H; Oktay G; Alanyali H; Küpelioğlu A; Ergör G; Füzün M
Dis Colon Rectum; 2004 Dec; 47(12):2184-94. PubMed ID: 15657672
[TBL] [Abstract][Full Text] [Related]
16. Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management.
Heinzerling JH; Huerta S
Curr Surg; 2006; 63(5):334-7. PubMed ID: 16971205
[TBL] [Abstract][Full Text] [Related]
17. [Surgical management of bevacizumab-associated peritonitis due to perforation].
Kube R; Meyer F; Bien N; Schmidt C; Mroczkowski P; Dalicho S; Lippert H
Zentralbl Chir; 2009 Sep; 134(5):462-7. PubMed ID: 19757347
[TBL] [Abstract][Full Text] [Related]
18. [Total mesorectal excison and colonic-J-pouch-anal anastomosis in the therapy of low rectal carcinoma--results in 116 patients].
Ommer A; Girona-Johannkemper M; Jung KP; Berg E
Zentralbl Chir; 2002 Sep; 127(9):775-80. PubMed ID: 12221559
[TBL] [Abstract][Full Text] [Related]
19. [Complications of chemotherapy in combination with bevacizumab for treating metastatic colorectal cancer].
Manikhas GM; Korolenko VO; Al'-Nekhmi AA; Antimonik NIu
Vopr Onkol; 2010; 56(5):613-6. PubMed ID: 21137245
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.
Kozloff M; Yood MU; Berlin J; Flynn PJ; Kabbinavar FF; Purdie DM; Ashby MA; Dong W; Sugrue MM; Grothey A;
Oncologist; 2009 Sep; 14(9):862-70. PubMed ID: 19726453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
